India: The upsides to reform
India's local drug companies have long benefited from a relaxed patent regime. All that will change on January 1 2005, when the country becomes fully TRIPs-compliant. V A Savangikar and Uma Baskaran, of Krishna & Saurastri in Mumbai (Bombay) explain how companies can make the most of the reforms
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
